The Crispr Baby Scientist Is Back. Here’s What He’s Doing Next
By Emily Mullin,
Wired
| 12. 21. 2022
In November 2018, Chinese scientist He Jiankui shocked the world when he announced, first on YouTube and then at an international scientific gathering in Hong Kong, that he had used Crispr to alter the genetic makeup of human embryos, which were used to establish pregnancies and resulted in the birth of the world’s first gene-edited babies.
Backlash against He was harsh and swift. Members of the scientific community condemned his experiments as unethical and voiced concerns over the babies’ health, about which little is known today. The Chinese government suspended his research, saying he violated medical regulations. In December 2019, a Chinese court found He guilty of illegal medical practices and sentenced him to three years' imprisonment. In light of He’s experiment, China has since adopted regulations prohibiting the modification of human embryos for reproductive purposes. He was released from prison in April.
In recent months, He has taken to Twitter and the Chinese social media platform Weibo to publicize his next steps. Previously a researcher at Southern University of Science and Technology in Shenzhen, He says...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...